TVGN - Tevogen Bio Holdings Narxning foydaga va o‘sish sur’atiga nisbati
Tevogen Bio Holdings (TVGN) qat'iy bioetika qoidalariga rioya qilgan holda, T-hujayra terapiyalarini yaratish jarayoniga ESG ekologik standartlarini joriy qilmoqda. GURU.Markets terminali PEG koeffitsiyenti asosida kompaniyaning real vaqtdagi baholashini taqdim etadi, bunda 0.00 qiymati ushbu metrikani aks ettiradi. Startapning dadil imidji onkologiya va viruslarga yo'naltirilgan tadqiqotlarning diversifikatsiyasi bilan to'ldirilgan bo'lib, bu biznesning o'sish potentsialini belgilaydi.
Tevogen Bio Holdings, Inc. (TVGN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi statistikasi:
- emitentning balans qiymati statistikasi:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Tevogen Bio Holdings|TVGN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Tevogen Bio Holdings, Inc.|TVGN - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Tevogen Bio Inc.|TVGN - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Tevogen Bio|Oraliq qoplama koeffitsiyenti tevogen.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
TVGN - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Tevogen Bio Holdings|TVGN - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Tevogen Bio Holdings|TVGN - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Tevogen Bio|TVGN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Tevogen Bio|TVGN - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi tevogen.com|TVGN - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Tevogen Bio Holdings
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:Tevogen Bio Holdings, Inc., TVGN
Tevogen Bio Holdings (TVGN) kompaniyasida hujayra terapiyasini ishlab chiqish laboratoriyalarning ekologik modernizatsiyasi va energiya samaradorligi uchun sezilarli xarajatlarni talab qiladi. P/E va o'sish sur'atlarining ushbu taqqoslovi aktivning bozor qiymati foyda dinamikasi bilan asoslangan yoki yo'qligini baholash imkonini beradi; birdan past qiymat biznesning qadrsizlanganini anglatadi, bu esa investorga kirish nuqtasini va kompaniyaning kengayishiga nisbatan kapital barqarorligini aniqlashga yordam beradi.
Raqobatdosh kompaniyalar
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Idec|Neurocrine Corp - Narx-foyda va o‘sish multiplikatori|regencellbioscience.com (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|ACAD (ACADIA Pharmaceuticals Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Xenon Pharmaceuticals (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narxning foydaga va o‘sish sur’atiga nisbati Supernus|O‘sish sur’atiga tuzatilgan narx-foyda catalystpharma.com CPRX|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics Inc.)|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven Ltd. BHVN|AMLX (Amylyx) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Trevi Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Precision Medicines)|AVXL: PEG multiplikatori|CBLL - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati prothena.com|Narx-foyda va o‘sish multiplikatori Alector (ALEC)|Narx-foyda va o‘sish multiplikatori ANNX (annexonbio.com)|OMER - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori NGNE (Neurogene Inc)|PEG multiplikatori AC Immune S.A. ACIU|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati NMRA|SCLX (Scilex Holding Company) - Narx-foyda va o‘sish multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ACOG|Narxning foydaga va o‘sish sur’atiga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori SAVA (Cassava)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - PEG multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Narx-foyda va o‘sish multiplikatori|CRVO (CervoMed, Inc.) - Narx-foyda va o‘sish multiplikatori|Narx-foyda va o‘sish multiplikatori Alterity Therapeutics Ltd|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc.|PepGen Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori JUNS (Jupiter Neurosciences Inc)|Narxning foydaga va o‘sish sur’atiga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - PEG multiplikatori|Klotho Neurosciences (KLTO) - Narx-foyda va o‘sish multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - PEG multiplikatori|NRXS: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HSDT|PEG multiplikatori Passage Bio Inc. (PASG)|Narxning foydaga va o‘sish sur’atiga nisbati bionomics.com.au NEUP|PEG multiplikatori Minerva Neurosciences Inc NERV|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN (Addex Therapeutics, Ltd.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Alzamend Neuro Inc. (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati protagenic.com|Pasithea Therapeutics - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori CRGT (Cortigent, Inc.)|Avenue Therapeutics - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell BCLI|PEG multiplikatori caratherapeutics.com CARA|Chromocell Therapeutics Corp. - PEG multiplikatori|eliemtx.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Intra-Cellular Therapies (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|LBPH (Longboard) - Narxning foydaga va o‘sish sur’atiga nisbati|MRNS (marinuspharma.com) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech NKGN|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharma (NRBO)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|Synaptogenix, Inc. - Narx-foyda va o‘sish multiplikatori|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical, Inc.)|CERE: PEG multiplikatori
